Anak dengan HIV di tengah pandemi
Assessing the impact of COVID-19 on access to health services for key populations and people living with HIV in Indonesia
World Hepatitis Day 2021
Hepatitis B and C coinfection
Community Discussion Regarding Access to Hepatitis Services and Co-infection
CHAI webinar speaker
Current RT-PCR test fee – August 2021
WHO Guideline recommendation from a research including Peduli Hati Bangsa
Covid-19 and Hepatitis B dan C Program Webinar
Approval of two Hepatitis C treatments for children aged 3 years or older
ITPC’s Summary of Covid-19 Impact on HIV Health Access in Indonesia – 2020
Hepatitis B vaccine schedule for children
National Guidance for Hepatitis C Services
Hepatitis A-E Transmission information
Follow-up Meeting on Hepatitis C Screening and Treatment for inmates in Jakarta Region
Covid-19 control during Ramadhan month
Peer Educator Training – ITPC
Q&A Alcoholic Hepatitis
Can people with liver disease receive the Covid-19 vaccine?
World Cancer Day
National Disaster January 21
Annual Report 2020
Who will be eligible to get Covid-19 vaccine
University of Queensland/CSL vaccine fails
Bridging The Gaps concluded : Part 4 (Final)
Bridging The Gaps concluded : Part 3
Bridging The Gaps Concluded : Part 2
Bridging The Gaps concluded : Part 1
Scientists Who Discovered Hepatitis C Virus Awarded Nobel Prize
Webinar Towards Ending of AIDS 2030
Hepatitis Handbook 2020
Diet and nutrition for Hepatitis C patients.
Webinar with @jaringanindonesiapositif
Daclatasvir’s procurement timeline
Peduli Hati Bangsa is now a member of World Hepatitis Alliance
Daclatasvir is here…from petition to realization.
Jakarta Lockdown Guidelines
WHO SEARO Virtual Event for World Hepatitis Day 2020
Meeting to discuss Daclatasvir stock-out
Highest tariff limit for COVID-19 Rapid Antibody Test.
The Importance of Vaccines for People with HIV
Our petition has been heard !
Hepatitis C Treatment in Indonesia
Dolutegravir has FDA Approval for Treating HIV in pediatrics.
Information on coronavirus and COVID-19 for people affected by Hepatitis B or Hepatitis C
Q&A about COVID-19, HIV and antiretroviral in Indonesia
COVID-19 and Liver Disease
Improvement of survival rate on liver-related patients by Hepatitis-C treatment
Coalition of liver associations calls for simplifying Hepatitis C care
Hepatitis A plagued Depok City